机器人辅助腹腔镜前列腺癌根治术与开放耻骨后根治性前列腺切除术的围手术期、肿瘤学及功能结局比较:一项随机临床试验
单中心随机对照试验将342例新诊断前列腺癌患者按1:1随机分组,327例接受手术(开放耻骨后根治性前列腺切除术156例,机器人辅助腹腔镜前列腺癌根治术171例)。两组90天并发症发生率相似(17.3% vs 11.1%,P=.107);机器人辅助组出血量和住院时间更少,18个月内泌尿功能评分更优,12个月内性功能评分更高,36个月肿瘤学结局无显著差异。
要点
- 两组90天并发症发生率分别为17.3%与11.1%,差异无统计学意义(P=.107)。
- 机器人辅助组中位出血量250.0 mL低于开放组的719.5 mL(P<.001),住院时间更短。
- 机器人辅助组3、6、18个月控尿率更高,3、6个月勃起率更高,36个月肿瘤学结局无显著差异。
核心结论
- 两组90天并发症发生率相似;机器人辅助腹腔镜前列腺癌根治术在1年时性功能结局更优,18个月时泌尿功能结局更优,36个月时肿瘤学结局相当。
研究设计与样本
- 单中心随机临床试验,354例新诊断前列腺癌患者评估合格,342例按1:1随机分组,最终327例接受手术(开放耻骨后根治性前列腺切除术156例,机器人辅助腹腔镜前列腺癌根治术171例)。
- 主要结局为90天并发症发生率;功能结局与生活质量评估至18个月,肿瘤学结局、生化复发无生存期及追加治疗评估至36个月。
主要发现
- 并发症发生于开放组27例(17.3%)与机器人辅助组19例(11.1%),差异无统计学意义(P=.107)。
- 机器人辅助组中位出血量250.0 mL低于开放组719.5 mL(P<.001),住院时间更短。
- 机器人辅助组泌尿EPIC中位评分在18个月内更优,3个月控尿率80.5% vs 64.7%(P=.002),6个月90.1% vs 81.6%(P=.036),18个月95.4% vs 78.8%(P<.001)。
- 机器人辅助组性功能EPIC及男性性健康量表中位评分在12个月内更高,3个月勃起率23.9% vs 5.3%(P=.001),6个月30.6% vs 6.9%(P<.001)。
- 18个月内生活质量及36个月内肿瘤学结局在两组间无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Limited high-quality studies have compared robot-assisted laparoscopic prostatectomy (RALP) vs open retropubic radical prostatectomy. We sought to compare their postoperative outcomes in a randomized setting. MATERIALS AND METHODS: In a single center, 354 men with newly diagnosed prostate cancer were assessed for eligibility; 342 were randomized (1:1). The primary outcome was 90-day complication rates. Functional outcomes and quality of life were assessed over 18 months, and oncological outcomes, biochemical recurrence-free survival, and additional treatment over 36 months. RESULTS: From 2014 to 18, 327 patients underwent surgery (retropubic radical prostatectomy = 156, RALP = 171). Complications occurred in 27 (17.3%) vs 19 (11.1%; P = .107). Patients undergoing RALP experienced lower median bleeding (250.0 vs 719.5 mL; P < .001) and shorter hospitalization time. Urinary EPIC (Expanded Prostate Cancer Index Composite) median scores were better for RALP over 18 months, with higher continence rate at 3 months (80.5% vs 64.7%; P = .002), 6 months (90.1% vs 81.6%; P = .036) and 18 months (95.4% vs 78.8%; P < .001). Sexual EPIC and Sexual Health Inventory for Men median scores were higher with RALP up to 12 months, while the potency rate was superior at 3 months (23.9% vs 5.3%; P = .001) and 6 months (30.6% vs 6.9%; P < .001). Quality of life over the 18 months and oncological outcomes over 36 months were not significantly different between arms. CONCLUSIONS: Complications at 90 days were similar. RALP showed superior sexual outcomes at 1 year, improved urinary outcomes at 18 months, and comparable oncological outcomes at 36 months. TRIAL REGISTRATION: Prospective Analysis of Robot-Assisted Surgery; NCT02292914. https://clinicaltrials.gov/ct2/show/NCT02292914?cond=NCT02292914&draw=2&rank=1.
引用
- Nahas WC, Rodrigues GJ, Rodrigues Gonçalves FA, et al. Perioperative, Oncological, and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial. J Urol. 2024. PMID: 38723593. doi:10.1097/JU.0000000000003967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。